Edition:
United Kingdom

Eleven Biotherapeutics Inc (EBIO.OQ)

EBIO.OQ on NASDAQ Stock Exchange Global Market

0.94USD
3:52pm GMT
Change (% chg)

$0.01 (+0.75%)
Prev Close
$0.93
Open
$0.93
Day's High
$0.94
Day's Low
$0.93
Volume
7,335
Avg. Vol
168,803
52-wk High
$2.53
52-wk Low
$0.63

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.369
Jun '17 0.00 -0.296
Mar '17 0.43 -0.246
FY 2016 Dec '16 0.82 -0.145
Sep '16 28.65 0.910
Jun '16 0.28 -0.327
Mar '16 0.23 -0.386
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 6.84 83.93 32.90
P/E High - Last 5 Yrs. 21.95 292.71 45.97
P/E Low - Last 5 Yrs. 21.95 91.44 24.37
Beta 3.54 0.90 0.89
Price to Sales (TTM) 1.26 110.72 5.77
Price to Book (MRQ) 1.45 13.56 5.41
Price to Tangible Book (MRQ) -- 14.02 6.98
Price to Cash Flow (TTM) 13.23 71.33 23.42
% Owned Institutions 31.95 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) 0.00 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago 2,527.42 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 9.26 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago 112.76 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 4.27 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -29.93 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) 8.88 -- --
EBITD - 5 Yr. Avg -286.84 -572.68 10.86
Operating Margin (TTM) 11.07 -717.10 4.64
Operating Margin - 5 Yr. Avg. -292.97 -594.00 6.26
Pre-Tax Margin (TTM) 8.64 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -299.28 -597.35 6.60
Net Profit Margin (TTM) 8.63 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -299.29 -600.21 2.91
Effective Tax Rate (TTM) 0.19 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 879,412 22,602,121 855,667,832
Net Income/Employee (TTM) 75,853 2,968,747 100,655,557
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.57 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 4.94 -1.05 10.98
Return on Assets - 5 Yr. Avg. -62.31 -0.57 12.37
Return on Investment (TTM) 5.29 1.66 14.43
Return on Investment - 5 Yr. Avg. -72.36 2.23 16.18
Return on Equity (TTM) 16.08 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 2,928.38 182.20 --
EPS (TTM) % 104.94 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Eleven Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -7.88 -11.06 37 53
13 Week -0.65 -5.49 96 62
26 Week -23.23 -29.07 51 77
52 Week -38.21 -47.63 46 50
YTD -20.42 -30.11 51 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.64%
# of Holders: 33
Total Shares Held: 14,847,161
3 Mo. Net Change: 8,424,455
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 12
# Reduced Positions: 5
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.